LifeMine Doses First Participant in Phase 1 Trial of Novel Immunosuppressive LIFE-001 LifeMine Therapeutics Inc., a clinical-stage biopharmaceutical company redefining small molecule discovery through its proprietary genomic search platform, has officially dosed the first participant in a Phase 1 clinical…
City of Hope Unveils Promising New Targeted Approach for Pancreatic Cancer In a significant stride forward in the battle against one of the most lethal forms of cancer, scientists at City of Hope®—a leading U.S. cancer research and treatment center—have…
Agitated Solutions Gets FDA IND Nod for Phase 3 Contrast Agent Trial Agitated Solutions, Incorporated (ASI), a medical technology company focused on cardiovascular imaging innovation, announced a pivotal regulatory milestone this week: the U.S. Food and Drug Administration (FDA) has…
Corcept Begins Trial of Relacorilant Combo in Resistant Ovarian Cancer Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage biopharmaceutical company focused on the discovery and development of innovative therapies that modulate the effects of the stress hormone cortisol to treat serious…
Verge Genomics Identifies Digital Biomarkers for Early ALS Progression in VRG50635 Trial Verge Genomics, a trailblazer in AI-powered drug discovery and development, today announced pivotal findings that could reshape the design and execution of clinical trials for neurodegenerative diseases. In…
Flatiron Health Partners with Massive Bio to Strengthen Patient Identification and Services In a strategic move poised to reshape the landscape of oncology clinical research, Flatiron Health, a leading health technology company dedicated to transforming clinical trials through the integration…
Akamis Bio Doses First Patient in Phase 1b Rectal Cancer Trial of NG-350A Akamis Bio, a clinical-stage biotechnology company at the forefront of immuno-oncology innovation, announced a major milestone in its development pipeline today with the initiation of patient enrollment…
eClinical Solutions Highlights 2025 Shift to Risk-Based Strategies and AI in Clinical Trials eClinical Solutions LLC, a global leader in digital clinical software and services, has released the findings of its 2025 Industry Outlook, offering critical insights into how clinical…
Tecan Enhances Specialty Diagnostics Portfolio With ELISA Kit Asset Acquisition Tecan Group (SIX Swiss Exchange: TECN) has announced a strategic agreement to acquire key ELISA immunoassay assets from Cisbio Bioassays SAS, a subsidiary of the global life sciences and diagnostics…
Columbus Unites to Support Life-Saving Research and Patient Care at the 2025 Susan G. Komen Race for the Cure Susan G. Komen®, the world’s leading breast cancer organization, has announced the return of its signature Race for the Cure event…
Personalized Cancer Vaccine Market & Clinical Trials Outlook 2025 – 18+ Vaccines in Development The “Personalized Cancer Vaccine Market Opportunity & Clinical Trials Outlook 2025″ report, now available from ResearchAndMarkets.com, highlights the growing significance of personalized cancer vaccines in the…
Neurogene Publishes Study on NGN-401 Gene Therapy for Rett Syndrome Neurogene Inc. (Nasdaq: NGNE), a clinical-stage biotechnology company dedicated to developing transformative genetic medicines for patients suffering from rare neurological disorders, has announced the publication of a peer-reviewed study detailing…